Sanofi is a leading global healthcare company whose mission is to support people with health challenges. 110,000 Sanofi employees in more than 100 countries all over the world take action daily transforming scientific innovations into healthcare solutions
Sanofi has been present in Russia since 1970 being a leader of a Russian pharmaceutical market and offering our patients a broad portfolio of original medicines, generics and OTC drugs in key therapeutic areas (diabetes, oncology, cardiovascular disorders, nervous system disorders, internal diseases, urology, thrombosis, rare diseases and multiple sclerosis), as well as vaccines.
To the date, “Sanofi-Aventis Vostok” is the first and only full cycle production site for novel insulin, its manufacturing capacities are sufficient to satisfy the needs of diabetic patients in modern insulins both in Russia and in European Union countries.
Novartis provides innovative healthcare solutions that address the evolving needs of patients and societies. Headquartered in Basel, Switzerland, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, cost-saving generic and biosimilar pharmaceuticals and eye-care. Novartis has leading positions globally in each of these areas. In 2017, the Group achieved net sales of USD 49.1 billion, while R&D throughout the Group amounted to approximately USD 9.0 billion. Novartis Group companies employs approximately 122,000 full-time-equivalent associates. Novartis products are sold in approximately 155 countries around the world.
Baltika Breweries, part of the Carlsberg Group − one of the largest companies in Russia in the sphere of consumer goods production. Continuous implementation of innovations, observance of high standards and integration of the sustainability principles have ensured the company’s first position on the Russian beer market since 1996.
the leader of the Russian beer market with the share of 31,9 % (according to 2017 Nielsen Retail Audit, Urban & Rural Russia);
more than 40 regional and national beer brands (Baltika, Tuborg, Zatecky Gus, Carlsberg) and 8 non-beer brands;
breweries in 8 cities of Russia: in Saint Petersburg, Yaroslavl, Tula, Voronezh, Rostov-on-Don, Samara, Khabarovsk, Novosibirsk;
about 9000 employees (average headcount in 2017);
a major Russian exporter of the products present in more than 75 countries of the world, in 43 of which Baltika Breweries is the only Russian exporter in beer category;
year of foundation – 1990.
AstraZeneca is a global, innovation-driven biopharmaceutical business that focuses on the discovery, development and commercialization of prescription medicines, primarily for the treatment of diseases in the main therapy areas – Oncology, Cardiovascular & Metabolic Diseases and Respiratory. The company also is selectively active in the areas of Autoimmunity, Neuroscience and Infection. AstraZeneca operates in over 100 countries and millions of patients use its innovative medicines worldwide.
Russia is one of the key markets for AstraZeneca. The company employs over 1000 people in more than 70 cities across Russia. About 40 of AstraZeneca’s innovative medicines are licensed for use in Russia. In October 2015, the AstraZeneca pharmaceutical plant was officially opened in Kaluga region.